Respiratory News and Research

RSS

Perinatal probiotic supplements do not prevent childhood asthma

There is insufficient evidence to support the use of probiotic supplements during pregnancy or infancy to prevent the development of asthma in infants, Canadian researchers report.

27 Dec 2013

Walgreens receives perfect score from CEI index for commitment to diversity and inclusion

Walgreens received a perfect score of 100 percent on the 2014 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate policies and practices related to LGBT workplace equality, administered by the Human Rights Campaign Foundation.

27 Dec 2013

Streptococcus biofilms persist on objects, surfaces in daycare center for longer periods after cleaning

Numerous scientific studies have concluded that two common bacteria that cause colds, ear infections, strep throat and more serious infections cannot live for long outside the human body.

27 Dec 2013

Ikaria shareholders to sell Commercial Business to Madison Dearborn Partners

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs of critically ill patients, announced today that its investor group and employee shareholders have reached a definitive agreement to sell the Commercial Business to Madison Dearborn Partners in a transaction valued at approximately $1.6 billion.

26 Dec 2013

Madison Dearborn Partners signs definitive agreement to acquire Ikaria

Madison Dearborn Partners announced today that it has signed a definitive agreement under which it will acquire a majority ownership position in Ikaria, Inc., a leading provider of proprietary and innovative therapies for the critical care units in hospitals.

25 Dec 2013

FDA extends PDUFA Priority Review action date for UC indication of Takeda's vedolizumab

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States Food & Drug Administration has extended the Prescription Drug User Fee Act Priority Review action date for the ulcerative colitis indication of Takeda's investigational biologic, vedolizumab.

24 Dec 2013

Duration of common pediatric respiratory infections estimated

An international research team has systematically reviewed the literature to formulate up-to-date estimates of the duration of common childhood respiratory tract infections.

24 Dec 2013

Older age linked to poor inhaler technique

Poor metered dose inhaler technique is common among older patients with asthma and is associated with reduced controller medication adherence, prospective study findings show.

24 Dec 2013

Research findings reveal how immune system responds to respiratory viral infections

An antibody that blocks a component of a key signaling pathway in the respiratory airways could help the immune system rid the body of the influenza virus, a new study suggests. The findings, from a team at The Research Institute at Nationwide Children's Hospital, not only offer a new approach to treating the flu, but also add new information about how the immune system responds to respiratory viral infections.

24 Dec 2013

FDA grants QIDP and Fast Track designations to TaiGen's nemonoxacin

TaiGen Biotechnology Company, Limited today announced that the U.S. Food and Drug Administration has granted nemonoxacin (Taigexyn) Qualified Infectious Disease Product and Fast Track designations for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.

23 Dec 2013

Cycle test reliable for dyspnea evaluation in obese COPD patients

Dyspnea in obese individuals with chronic obstructive pulmonary disease can be evaluated reliably by cycle ergometry as well as a treadmill test, researchers have found.

20 Dec 2013

ATS, Springer to collaborate on book series, Respiratory Medicine

Springer and the American Thoracic Society (ATS) have entered into a partnership to collaborate on the book series Respiratory Medicine.

20 Dec 2013

Walgreen's net earnings increase $695M to 68.3% in fiscal 2014 first quarter

Walgreen Co. today announced earnings and sales results for the first quarter of fiscal year 2014 ended Nov. 30. Net earnings determined in accordance with generally accepted accounting principles (GAAP) for the fiscal 2014 first quarter were $695 million, a 68.3 percent increase from $413 million in the year-ago quarter.

20 Dec 2013

Auxilium seeks FDA approval for XIAFLEX sBLA to treat multiple Dupuytren's contracture cords concurrently

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced the submission of a supplemental Biologics License Application to the U.S. Food and Drug Administration requesting approval of XIAFLEX (collagenase clostridium histolyticum, or CCH) for the treatment of multiple Dupuytren's contracture cords concurrently.

20 Dec 2013

New antibody could boost strength, muscle mass in patients with cancer and other diseases

A new antibody could dramatically boost strength and muscle mass in patients with cancer, chronic obstructive pulmonary disease, sporadic inclusion body myositis, and in elderly patients with sarcopenia according to research published ahead of print in the journal Molecular and Cellular Biology.

20 Dec 2013

TB-causing bacteria appear to mask their identity to avoid recognition by infection-killing cells

TB-causing bacteria appear to mask their identity to avoid recognition by infection-killing cells in the upper airways. The bacteria call up more permissive white blood cells in the deeper regions of the lungs and hitch a ride inside them to get into the host's body.

20 Dec 2013

Amgen reports that Phase 3 DESCARTES study for high cholesterol meets primary endpoint

Amgen today announced that the Phase 3 DESCARTES (Durable Effect of PCSK9 Antibody CompARed wiTh PlacEbo Study) study evaluating the long-term 52-week safety and efficacy of evolocumab for the treatment of high cholesterol met its primary endpoint of percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at week 52.

20 Dec 2013

Australian Therapeutic Goods Administration approves Genzyme's Lemtrada for multiple sclerosis

Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration has approved Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis for patients with active disease defined by clinical or imaging features to slow the accumulation of physical disability and reduce the frequency of clinical relapses.

19 Dec 2013

UVA earns national award for video detailing efforts to improve quality of care for children with asthma

For a video detailing efforts to improve the quality of care for children with asthma, University of Virginia Health System has earned a national award from the Robert Wood Johnson Foundation (RWJF).

19 Dec 2013

COPD undertreatment widespread

A study has shown that undertreatment of chronic obstructive pulmonary disease is highly prevalent.

19 Dec 2013

Respiratory News and Research

Perinatal probiotic supplements do not prevent childhood asthma

Walgreens receives perfect score from CEI index for commitment to diversity and inclusion

Streptococcus biofilms persist on objects, surfaces in daycare center for longer periods after cleaning

Ikaria shareholders to sell Commercial Business to Madison Dearborn Partners

Madison Dearborn Partners signs definitive agreement to acquire Ikaria

FDA extends PDUFA Priority Review action date for UC indication of Takeda's vedolizumab

Duration of common pediatric respiratory infections estimated

Older age linked to poor inhaler technique

Research findings reveal how immune system responds to respiratory viral infections

FDA grants QIDP and Fast Track designations to TaiGen's nemonoxacin

Cycle test reliable for dyspnea evaluation in obese COPD patients

ATS, Springer to collaborate on book series, Respiratory Medicine

Walgreen's net earnings increase $695M to 68.3% in fiscal 2014 first quarter

Auxilium seeks FDA approval for XIAFLEX sBLA to treat multiple Dupuytren's contracture cords concurrently

New antibody could boost strength, muscle mass in patients with cancer and other diseases

TB-causing bacteria appear to mask their identity to avoid recognition by infection-killing cells

Amgen reports that Phase 3 DESCARTES study for high cholesterol meets primary endpoint

Australian Therapeutic Goods Administration approves Genzyme's Lemtrada for multiple sclerosis

UVA earns national award for video detailing efforts to improve quality of care for children with asthma

COPD undertreatment widespread

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News